Stockreport

Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA-051 Nasal Spray

AptarGroup, Inc.  (ATR) 
Last aptargroup, inc. earnings: 4/30 05:04 pm Check Earnings Report
US:NYSE Investor Relations: investors.aptar.com
PDF Use of Aptar Pharma’s UDS Powder system supports the development of a next-generation, virus-agnostic nasal spray being evaluated for its potential to help protect again [Read more]